Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Momenta Pharmaceuticals Inc (MNTA)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1235010.
Total stock buying since 2014: $0.
Total stock sales since 2014: $79,248,629.
Total stock option exercises since 2014: $27,019,701.
Table 3. Detailed insider trading at Momenta Pharmaceuticals Inc (MNTA) , Part 5
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2015-06-04 | Wheeler Craig A (President) | Option Ex | 83,333 | 16.18 | 1,348,327 |
| 2015-06-01 | Roach James M. (Senior VP, Development and Chi) | Sale | 25,000 | 21.70 | 542,500 |
| 2015-06-01 | Roach James M. (Senior VP, Development and Chi) | Option Ex | 25,000 | 7.41 | 185,250 |
| 2015-06-01 | Leicher Bruce (SVP & General Counsel) | Sale | 40,000 | 21.00 | 840,000 |
| 2015-06-01 | Leicher Bruce (SVP & General Counsel) | Option Ex | 40,000 | 15.12 | 604,800 |
| 2015-05-26 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 254 | 19.80 | 5,029 |
| 2015-05-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 360 | 19.68 | 7,084 |
| 2015-05-20 | Leicher Bruce (SVP & General Counsel) | Sale | 227 | 19.68 | 4,467 |
| 2015-05-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 227 | 19.68 | 4,467 |
| 2015-05-20 | Shea Richard P (SVP, CFO) | Sale | 227 | 19.68 | 4,467 |
| 2015-05-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 19.68 | 4,467 |
| 2015-05-20 | Wheeler Craig A (President) | Sale | 1,766 | 19.68 | 34,754 |
| 2015-05-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 617 | 19.63 | 12,111 |
| 2015-05-19 | Leicher Bruce (SVP & General Counsel) | Sale | 426 | 19.63 | 8,362 |
| 2015-05-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 624 | 19.63 | 12,249 |
| 2015-05-19 | Shea Richard P (SVP, CFO) | Sale | 406 | 19.63 | 7,969 |
| 2015-05-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 406 | 19.63 | 7,969 |
| 2015-05-19 | Wheeler Craig A (President) | Sale | 2,061 | 19.67 | 40,539 |
| 2015-05-15 | Roach James M. (Senior VP, Development and Chi) | Sale | 311 | 19.96 | 6,207 |
| 2015-05-15 | Leicher Bruce (SVP & General Counsel) | Sale | 267 | 19.96 | 5,329 |
| 2015-05-15 | Shea Richard P (SVP, CFO) | Sale | 145 | 19.96 | 2,894 |
| 2015-05-15 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 215 | 19.96 | 4,291 |
| 2015-05-15 | Wheeler Craig A (President) | Sale | 1,766 | 19.92 | 35,178 |
| 2015-05-12 | Clarke John K | Sale | 38,400 | 19.96 | 766,464 |
| 2015-05-12 | Clarke John K | Option Ex | 38,400 | 10.44 | 400,896 |
| 2015-05-11 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 33,625 | 20.70 | 696,037 |
| 2015-05-11 | Bishop John E (Senior VP, Pharmaceutical Scie) | Option Ex | 33,625 | 16.16 | 543,211 |
| 2015-05-06 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 493 | 19.05 | 9,391 |
| 2015-04-23 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 34,000 | 19.95 | 678,300 |
| 2015-04-23 | Wheeler Craig A (President) | Sale | 51,667 | 20.00 | 1,033,340 |
| 2015-04-23 | Wheeler Craig A (President) | Option Ex | 41,667 | 16.18 | 674,172 |
| 2015-04-20 | Wheeler Craig A (President) | Sale | 6,269 | 18.75 | 117,543 |
| 2015-04-17 | Leicher Bruce (SVP & General Counsel) | Sale | 12,910 | 18.05 | 233,025 |
| 2015-04-16 | Roach James M. (Senior VP, Development and Chi) | Sale | 50,000 | 18.70 | 935,000 |
| 2015-04-16 | Roach James M. (Senior VP, Development and Chi) | Option Ex | 50,000 | 7.41 | 370,500 |
| 2015-04-16 | Leicher Bruce (SVP & General Counsel) | Sale | 40,000 | 20.00 | 800,000 |
| 2015-04-16 | Leicher Bruce (SVP & General Counsel) | Option Ex | 40,000 | 15.12 | 604,800 |
| 2015-03-16 | Shea Richard P (SVP, CFO) | Sale | 23,093 | 15.10 | 348,704 |
| 2015-03-11 | Franken Michael (President, Biosimilars Busines) | Sale | 512 | 14.71 | 7,531 |
| 2015-03-05 | Shea Richard P (SVP, CFO) | Sale | 23,364 | 14.90 | 348,123 |
| 2015-02-25 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 64 | 13.20 | 844 |
| 2015-02-24 | Roach James M. (Senior VP, Development and Chi) | Sale | 192 | 13.56 | 2,603 |
| 2015-02-24 | Leicher Bruce (SVP & General Counsel) | Sale | 192 | 13.56 | 2,603 |
| 2015-02-24 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 211 | 13.56 | 2,861 |
| 2015-02-24 | Shea Richard P (SVP, CFO) | Sale | 192 | 13.56 | 2,603 |
| 2015-02-24 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 211 | 13.56 | 2,861 |
| 2015-02-24 | Wheeler Craig A (President) | Sale | 2,110 | 13.52 | 28,527 |
| 2015-02-23 | Roach James M. (Senior VP, Development and Chi) | Sale | 199 | 12.93 | 2,573 |
| 2015-02-23 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 129 | 12.93 | 1,667 |
| 2015-02-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 249 | 13.40 | 3,336 |
| 2015-02-20 | Leicher Bruce (SVP & General Counsel) | Sale | 227 | 13.40 | 3,041 |
| 2015-02-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 227 | 13.40 | 3,041 |
| 2015-02-20 | Shea Richard P (SVP, CFO) | Sale | 227 | 13.40 | 3,041 |
| 2015-02-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 13.40 | 3,041 |
| 2015-02-20 | Wheeler Craig A (President) | Sale | 1,688 | 13.37 | 22,568 |
| 2015-02-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 1,664 | 12.91 | 21,482 |
| 2015-02-19 | Leicher Bruce (SVP & General Counsel) | Sale | 1,664 | 12.91 | 21,482 |
| 2015-02-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 1,541 | 12.91 | 19,894 |
| 2015-02-19 | Shea Richard P (SVP, CFO) | Sale | 1,585 | 12.91 | 20,462 |
| 2015-02-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 1,585 | 12.91 | 20,462 |
| 2015-02-19 | Wheeler Craig A (President) | Sale | 7,875 | 13.52 | 106,470 |
| 2015-02-18 | Roach James M. (Senior VP, Development and Chi) | Sale | 252 | 11.91 | 3,001 |
| 2015-02-18 | Leicher Bruce (SVP & General Counsel) | Sale | 312 | 11.91 | 3,715 |
| 2015-02-18 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 252 | 11.91 | 3,001 |
| 2015-02-18 | Shea Richard P (SVP, CFO) | Sale | 169 | 11.91 | 2,012 |
| 2015-02-18 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 252 | 11.91 | 3,001 |
| 2015-02-18 | Wheeler Craig A (President) | Sale | 1,688 | 11.91 | 20,104 |
| 2015-02-11 | Downey Bruce | Option Ex | 10,000 | 8.85 | 88,500 |
| 2015-01-16 | Shea Richard P (SVP, CFO) | Option Ex | 11,250 | 6.88 | 77,400 |
| 2014-12-15 | Shapiro Bennett M | Sale | 5,800 | 12.19 | 70,702 |
| 2014-12-11 | Franken Michael (President, Biosimilars Busines) | Sale | 2,047 | 12.29 | 25,157 |
| 2014-12-10 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Option Ex | 25,000 | 6.88 | 172,000 |
| 2014-12-01 | Shapiro Bennett M | Sale | 9,903 | 12.00 | 118,836 |
| 2014-11-28 | Shapiro Bennett M | Sale | 1,897 | 12.00 | 22,764 |
| 2014-11-26 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 64 | 11.60 | 742 |
| 2014-11-25 | Roach James M. (Senior VP, Development and Chi) | Sale | 192 | 11.67 | 2,240 |
| 2014-11-25 | Leicher Bruce (SVP & General Counsel) | Sale | 192 | 11.67 | 2,240 |
| 2014-11-25 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 211 | 11.67 | 2,462 |
| 2014-11-25 | Shea Richard P (SVP, CFO) | Sale | 192 | 11.67 | 2,240 |
| 2014-11-25 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 211 | 11.67 | 2,462 |
| 2014-11-25 | Wheeler Craig A (President) | Sale | 2,210 | 11.59 | 25,613 |
| 2014-11-24 | Roach James M. (Senior VP, Development and Chi) | Sale | 199 | 11.53 | 2,294 |
| 2014-11-24 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 135 | 11.53 | 1,556 |
| 2014-11-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 250 | 11.13 | 2,782 |
| 2014-11-20 | Leicher Bruce (SVP & General Counsel) | Sale | 228 | 11.13 | 2,537 |
| 2014-11-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 228 | 11.13 | 2,537 |
| 2014-11-20 | Shea Richard P (SVP, CFO) | Sale | 228 | 11.13 | 2,537 |
| 2014-11-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 228 | 11.13 | 2,537 |
| 2014-11-20 | Wheeler Craig A (President) | Sale | 1,768 | 11.10 | 19,624 |
| 2014-11-17 | Roach James M. (Senior VP, Development and Chi) | Sale | 217 | 10.64 | 2,308 |
| 2014-11-17 | Leicher Bruce (SVP & General Counsel) | Sale | 269 | 10.64 | 2,862 |
| 2014-11-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 217 | 10.64 | 2,308 |
| 2014-11-17 | Shea Richard P (SVP, CFO) | Sale | 146 | 10.64 | 1,553 |
| 2014-11-17 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 217 | 10.64 | 2,308 |
| 2014-11-17 | Wheeler Craig A (President) | Sale | 1,768 | 10.58 | 18,705 |
| 2014-10-17 | Sulat James R | Option Ex | 5,000 | 8.85 | 44,250 |
| 2014-10-03 | Shapiro Bennett M | Sale | 3,723 | 12.00 | 44,676 |
| 2014-09-12 | Hutt Peter Barton | Sale | 3,640 | 11.42 | 41,568 |
| 2014-08-27 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 64 | 12.00 | 768 |
| 2014-08-25 | Roach James M. (Senior VP, Development and Chi) | Sale | 192 | 11.45 | 2,198 |
| 2014-08-25 | Leicher Bruce (SVP & General Counsel) | Sale | 192 | 11.45 | 2,198 |
| 2014-08-25 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 346 | 11.45 | 3,961 |
| 2014-08-25 | Shea Richard P (SVP, CFO) | Sale | 192 | 11.45 | 2,198 |
| 2014-08-25 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 211 | 11.45 | 2,415 |
| 2014-08-25 | Wheeler Craig A (President) | Sale | 2,209 | 11.45 | 25,293 |
| 2014-08-22 | Roach James M. (Senior VP, Development and Chi) | Sale | 199 | 11.32 | 2,252 |
| 2014-08-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 250 | 11.54 | 2,885 |
| 2014-08-20 | Leicher Bruce (SVP & General Counsel) | Sale | 228 | 11.54 | 2,631 |
| 2014-08-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 228 | 11.54 | 2,631 |
| 2014-08-20 | Shea Richard P (SVP, CFO) | Sale | 228 | 11.54 | 2,631 |
| 2014-08-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 228 | 11.54 | 2,631 |
| 2014-08-20 | Wheeler Craig A (President) | Sale | 1,768 | 11.54 | 20,402 |
| 2014-08-18 | Shea Richard P (SVP, CFO) | Sale | 145 | 11.84 | 1,716 |
| 2014-08-15 | Roach James M. (Senior VP, Development and Chi) | Sale | 217 | 11.75 | 2,549 |
| 2014-08-15 | Leicher Bruce (SVP & General Counsel) | Sale | 268 | 11.75 | 3,149 |
| 2014-08-15 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 217 | 11.75 | 2,549 |
| 2014-08-15 | Shapiro Bennett M | Sale | 3,722 | 12.00 | 44,664 |
| 2014-08-15 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 217 | 11.75 | 2,549 |
| 2014-08-15 | Wheeler Craig A (President) | Sale | 1,768 | 11.75 | 20,774 |
| 2014-08-13 | Shapiro Bennett M | Sale | 3,721 | 12.00 | 44,652 |
| 2014-05-27 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 64 | 12.24 | 783 |
| 2014-05-23 | Roach James M. (Senior VP, Development and Chi) | Sale | 192 | 12.09 | 2,321 |
| 2014-05-23 | Leicher Bruce (SVP & General Counsel) | Sale | 192 | 12.09 | 2,321 |
| 2014-05-23 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 346 | 12.09 | 4,183 |
| 2014-05-23 | Shea Richard P (SVP, CFO) | Sale | 192 | 12.09 | 2,321 |
| 2014-05-23 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 211 | 12.09 | 2,550 |
| 2014-05-23 | Wheeler Craig A (President) | Sale | 2,110 | 12.06 | 25,446 |
| 2014-05-22 | Roach James M. (Senior VP, Development and Chi) | Sale | 199 | 11.74 | 2,336 |
| 2014-05-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 250 | 12.08 | 3,020 |
| 2014-05-20 | Leicher Bruce (SVP & General Counsel) | Sale | 227 | 12.08 | 2,742 |
| 2014-05-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 227 | 12.08 | 2,742 |
| 2014-05-20 | Shea Richard P (SVP, CFO) | Sale | 227 | 12.08 | 2,742 |
| 2014-05-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 12.08 | 2,742 |
| 2014-05-20 | Wheeler Craig A (President) | Sale | 1,688 | 12.08 | 20,391 |
| 2014-05-15 | Roach James M. (Senior VP, Development and Chi) | Sale | 217 | 11.09 | 2,406 |
| 2014-05-15 | Leicher Bruce (SVP & General Counsel) | Sale | 269 | 11.09 | 2,983 |
| 2014-05-15 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 217 | 11.09 | 2,406 |
| 2014-05-15 | Shea Richard P (SVP, CFO) | Sale | 146 | 11.09 | 1,619 |
| 2014-05-15 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 217 | 11.09 | 2,406 |
| 2014-05-15 | Wheeler Craig A (President) | Sale | 1,687 | 11.09 | 18,708 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA,
CIK number 1235010) see
the Securities and Exchange Commission (SEC) website.